|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-1.99/-3.25
|
企业价值
58.40M
|
资产负债 |
每股账面净值
4.12
|
现金流量 |
现金流量率
--
|
损益表 |
收益
51.13M
|
每股收益
3.92
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/12/24 13:34 EST
同行比较之报价最少15分钟延迟
业务概览
|
|||
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada. |